Dual-Target PROTAC Suppresses AML in Mouse Model
A peer-reviewed Oncogene study describes A9, a celastrol-derived cereblon-recruiting PROTAC that degrades IKKβ and/or NR4A1, kills AML cell lines and primary samples, and suppresses KMT2A::MLLT3 leukemia in mice without the neutrophilia associated with direct…
